JSTOR “Regretted” Fraud Case

After the suicide of Reddit developer Aaron Swartz, JSTOR says it regrets being involved in the federal computer fraud case against him.

Written byBeth Marie Mole
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Aaron SwartzWIKIMEDIA, SAGE ROSSComputer programming prodigy Aaron Swartz, an early developer of the popular social news site Reddit, was found hanged on Friday (January 11), in an apparent suicide in his New York City apartment. His untimely death came amid federal hacking charges claiming he had gained illegal access to the Massachusetts Institute of Technology (MIT) computer networks and JSTOR—a subscription-only, online journal database—allegedly downloading 4.8 million scholarly articles and documents. Though he later returned the stolen files and JSTOR did not press charges, Swartz, 26, still faced criminal charges, up to 35 years in prison, and $1 million dollars in fines. Family and friends claim that the impending trial, which was set for April, and the potential penalties contributed to Swartz’s death. JSTOR has since released a public statement saying it “regretted” ever being involved in the case.

“He was a truly gifted person who made important contributions to the development of the internet and the web from which we all benefit,” JSTOR said in a statement. “The case is one that we ourselves had regretted being drawn into from the outset.” In the statement, JSTOR also offered condolences to Swartz’s family.

Swartz’s family and business partner released their own statement, linking the pending trial to Swartz’s death. “Aaron’s death is not simply a personal tragedy. It is the product of a criminal justice system rife with intimidation and prosecutorial overreach. Decisions made by officials in the Massachusetts U.S. Attorney’s office and at MIT contributed to his death. The US Attorney’s office pursued an exceptionally harsh array of charges, carrying potentially over 30 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies